Cargando…
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease
Background: We investigated how the non-medical switching (NMS) between Etanercept (ETN)/originator and SB4/biosimilar affects treatment efficacy in a rheumatic disease (RD) cohort, evaluating some laboratory parameters as loss of efficacy predictors after NMS. Methods: We enrolled 124 patients with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316161/ https://www.ncbi.nlm.nih.gov/pubmed/35887671 http://dx.doi.org/10.3390/jpm12071174 |
_version_ | 1784754739635814400 |
---|---|
author | Benucci, Maurizio Damiani, Arianna Russo, Edda Li Gobbi, Francesca Grossi, Valentina Amedei, Amedeo Infantino, Maria Manfredi, Mariangela |
author_facet | Benucci, Maurizio Damiani, Arianna Russo, Edda Li Gobbi, Francesca Grossi, Valentina Amedei, Amedeo Infantino, Maria Manfredi, Mariangela |
author_sort | Benucci, Maurizio |
collection | PubMed |
description | Background: We investigated how the non-medical switching (NMS) between Etanercept (ETN)/originator and SB4/biosimilar affects treatment efficacy in a rheumatic disease (RD) cohort, evaluating some laboratory parameters as loss of efficacy predictors after NMS. Methods: We enrolled 124 patients with RD (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis): 79 switchers from ETN/originator to SB4 and 45 naïve patients receiving SB4 (first biological treatment). At baseline, 6 (T1), and 12 months (T2), clinical and laboratory parameters were evaluated. Results: In naïve patients, TNF-α significantly increased at T1 in responders (NR) and non-responders (NNR). TNF-α was lower in NNR than in NR at T1 and T2. In NR and NNR, drug levels (DL) increased between T1 and T2. However, DLs were lower in NNR than in NR at T1 and T2. TNF-α was higher in switcher responders (SR) than in non-responders (SNR) at T1 and T2. In SNR, DLs were higher at baseline than in SR, but they decreased significantly at T1 and T2. Conclusions: We observed a decrease in DL and TNF-α levels after NMS in SNR. Moreover, in naïve patients, DL and TNF-α levels were higher in NR than in NNR. Monitoring DL and TNF-α levels may represent a future precision medicine approach to predict loss of efficacy after NMS. |
format | Online Article Text |
id | pubmed-9316161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93161612022-07-27 Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease Benucci, Maurizio Damiani, Arianna Russo, Edda Li Gobbi, Francesca Grossi, Valentina Amedei, Amedeo Infantino, Maria Manfredi, Mariangela J Pers Med Article Background: We investigated how the non-medical switching (NMS) between Etanercept (ETN)/originator and SB4/biosimilar affects treatment efficacy in a rheumatic disease (RD) cohort, evaluating some laboratory parameters as loss of efficacy predictors after NMS. Methods: We enrolled 124 patients with RD (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis): 79 switchers from ETN/originator to SB4 and 45 naïve patients receiving SB4 (first biological treatment). At baseline, 6 (T1), and 12 months (T2), clinical and laboratory parameters were evaluated. Results: In naïve patients, TNF-α significantly increased at T1 in responders (NR) and non-responders (NNR). TNF-α was lower in NNR than in NR at T1 and T2. In NR and NNR, drug levels (DL) increased between T1 and T2. However, DLs were lower in NNR than in NR at T1 and T2. TNF-α was higher in switcher responders (SR) than in non-responders (SNR) at T1 and T2. In SNR, DLs were higher at baseline than in SR, but they decreased significantly at T1 and T2. Conclusions: We observed a decrease in DL and TNF-α levels after NMS in SNR. Moreover, in naïve patients, DL and TNF-α levels were higher in NR than in NNR. Monitoring DL and TNF-α levels may represent a future precision medicine approach to predict loss of efficacy after NMS. MDPI 2022-07-19 /pmc/articles/PMC9316161/ /pubmed/35887671 http://dx.doi.org/10.3390/jpm12071174 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Benucci, Maurizio Damiani, Arianna Russo, Edda Li Gobbi, Francesca Grossi, Valentina Amedei, Amedeo Infantino, Maria Manfredi, Mariangela Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease |
title | Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease |
title_full | Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease |
title_fullStr | Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease |
title_full_unstemmed | Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease |
title_short | Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease |
title_sort | predicting loss of efficacy after non-medical switching: correlation between circulating tnf-α levels and sb4 in etanercept to sb4 switchers and naïve patients with rheumatic disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316161/ https://www.ncbi.nlm.nih.gov/pubmed/35887671 http://dx.doi.org/10.3390/jpm12071174 |
work_keys_str_mv | AT benuccimaurizio predictinglossofefficacyafternonmedicalswitchingcorrelationbetweencirculatingtnfalevelsandsb4inetanercepttosb4switchersandnaivepatientswithrheumaticdisease AT damianiarianna predictinglossofefficacyafternonmedicalswitchingcorrelationbetweencirculatingtnfalevelsandsb4inetanercepttosb4switchersandnaivepatientswithrheumaticdisease AT russoedda predictinglossofefficacyafternonmedicalswitchingcorrelationbetweencirculatingtnfalevelsandsb4inetanercepttosb4switchersandnaivepatientswithrheumaticdisease AT ligobbifrancesca predictinglossofefficacyafternonmedicalswitchingcorrelationbetweencirculatingtnfalevelsandsb4inetanercepttosb4switchersandnaivepatientswithrheumaticdisease AT grossivalentina predictinglossofefficacyafternonmedicalswitchingcorrelationbetweencirculatingtnfalevelsandsb4inetanercepttosb4switchersandnaivepatientswithrheumaticdisease AT amedeiamedeo predictinglossofefficacyafternonmedicalswitchingcorrelationbetweencirculatingtnfalevelsandsb4inetanercepttosb4switchersandnaivepatientswithrheumaticdisease AT infantinomaria predictinglossofefficacyafternonmedicalswitchingcorrelationbetweencirculatingtnfalevelsandsb4inetanercepttosb4switchersandnaivepatientswithrheumaticdisease AT manfredimariangela predictinglossofefficacyafternonmedicalswitchingcorrelationbetweencirculatingtnfalevelsandsb4inetanercepttosb4switchersandnaivepatientswithrheumaticdisease |